BEAUTY HEALTH Reports Second Quarter FY2023 Earnings Results on August 9th

August 17, 2023

☀️Earnings Overview

On August 9, 2023, BEAUTY HEALTH ($NASDAQ:SKIN) reported its earnings results for the second quarter of FY2023 (ending June 30, 2023). The company’s total revenue for the quarter was USD 117.5 million, a 13.5% increase compared to the prior year. Unfortunately, net income saw a decrease of 57.1% year over year, totalling USD 3.4 million.

Price History

The stock opened at $8.0 and closed at $7.1, representing a drop of 5.4% from its prior closing price of $7.5. Overall, BEAUTY HEALTH shareholders experienced a difficult second quarter with the stock dropping by 5.4%. However, the company’s reported decrease in operating costs and net income may bring optimism to investors in the coming quarters. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Beauty Health. More…

    Total Revenues Net Income Net Margin
    390.68 -10.28 -4.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Beauty Health. More…

    Operations Investing Financing
    -27.84 -35.47 -206.22
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Beauty Health. More…

    Total Assets Total Liabilities Book Value Per Share
    1.01k 845.63 1.22
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Beauty Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    30.0% -1.2%
    FCF Margin ROE ROA
    -11.9% -1.8% -0.3%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we analysed the financials of BEAUTY HEALTH and have determined that it is a high risk investment. We detected 3 risk warnings within the organization’s income sheet, balance sheet, and cashflow statement. If you are interested in learning more about BEAUTY HEALTH’s financials, you can become a registered user and gain access to our detailed reports. Our analysis reveals that BEAUTY HEALTH has potential for success, but their current financial situation is not entirely secure. We suggest that investors thoroughly assess the company’s finances before making any commitments. As a registered user, you can view our complete findings and make an informed decision about whether or not to invest in BEAUTY HEALTH. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The company’s products are available in more than 30 countries and it has a strong presence in the United States, Europe, and Asia. The company’s products are sold through a network of distributors, retailers, and online retailers. The company has a strong focus on research and development and has a team of scientists that are constantly innovating new products. The company’s products are backed by a 100% satisfaction guarantee.

    – Hims & Hers Health Inc ($NYSE:HIMS)

    Hims & Hers Health Inc. is a digital healthcare company that offers direct-to-consumer telehealth and online pharmacy services. The company was founded in 2017 and is headquartered in San Francisco, California. As of 2022, the company had a market cap of 880.33M and a ROE of -15.86%. The company offers a range of services including primary care, sexual health, mental health, and more.

    – Yoshitsu Co Ltd ($NASDAQ:TKLF)

    The company has a market cap of 47.13M as of 2022. The company’s ROE for the same period is 14.38%. The company is engaged in the business of manufacturing textile products.

    – CI Medical Co Ltd ($TSE:3540)

    Founded in 1971, CIC Medical is a leading provider of medical devices and services. The company’s products are used in a variety of medical applications, including surgery, diagnostics, and patient care. CIC Medical has a market cap of 51.4 billion as of 2022 and a return on equity of 15.93%. The company’s products are used in a variety of medical applications, including surgery, diagnostics, and patient care.


    Beauty Health, a publicly traded company, recently reported its second quarter earnings for FY2023. Revenue increased by 13.5% compared to the same period last year, totaling USD 117.5 million. Despite the positive growth in revenue, net income saw a 57.1% decrease year over year, resulting in a total of USD 3.4 million. This news caused the stock price of Beauty Health to decline on the same day.

    Investors should be aware of this lower-than-expected net income when considering an investment in Beauty Health. Long-term investors may find the company’s revenue growth encouraging, however, as this signals potential for future growth and stability.

    Recent Posts

    Leave a Comment